Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Epidemiological Features and Prognosis for Primary Gastrointestinal Follicular Lymphoma Publisher Pubmed



Li X1 ; Gao F1 ; Meng X1 ; Zhang X2 ; Sun C1 ; Liu H1 ; Yu J1 ; Liu X1 ; Han X1 ; Li L1 ; Qiu L1 ; Qian Z1 ; Zhou S1 ; Gong W3 Show All Authors
Authors
  1. Li X1
  2. Gao F1
  3. Meng X1
  4. Zhang X2
  5. Sun C1
  6. Liu H1
  7. Yu J1
  8. Liu X1
  9. Han X1
  10. Li L1
  11. Qiu L1
  12. Qian Z1
  13. Zhou S1
  14. Gong W3
  15. Golchehre Z4
  16. Chavoshzadeh Z5
  17. Ren X6
  18. Wang X1
  19. Zhang H1

Source: British Journal of Haematology Published:2024


Abstract

Primary gastrointestinal follicular lymphoma (PGI-FL) is a rare extra-nodal lymphoma. Its epidemiology and prognosis remain unclear. We performed a retrospective analysis of eligible patients with 1648 PGI-FL and 34 892 nodal FL (N-FL) in the Surveillance, Epidemiology and End Results (SEER) database. The age-adjusted average annual incidence of PGI-FL was 0.111/100000. The median overall survival (OS) for PGI-FL and N-FL patients was 207 and 165 months respectively. The 5-year diffuse large B-cell lymphoma (DLBCL) transformation rates were 2.1% and 2.6% respectively. Age, sex, grade, Ann Arbor stage, primary site and radiation were independent prognostic factors (p < 0.05). Nomograms were constructed to predict 1-, 5- and 10-year OS and disease-specific survival (DSS). The receiver operating characteristic curves and calibration plots showed the established nomograms had robust and accurate performance. Patients were classified into three risk groups according to nomogram score. In conclusion, the incidence of PGI-FL has increased over the past 40 years, and PGI-FL has a better prognosis and a lower DLBCL transformation rate than N-FL. The nomograms were developed and validated as an individualized tool to predict survival. Patients were divided into three risk groups to assist clinicians in identifying high-risk patients and choosing the optimal individualized treatments. © 2024 British Society for Haematology and John Wiley & Sons Ltd.
Other Related Docs
8. Primary Breast Lymphoma (Pbl) in Men — a Systematic Review, Oncology in Clinical Practice (2021)